Drug archive
Gemtuzumab Ozogamicin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Monoclonal antibody
- antineoplastic
Description
Gemtuzumab ozogamicin (gem-TOO-ze-mab oh-zoh-GAM-ih-sin)is a monoclonal antibody. It is used to treat a certain type of leukemia which has recurred in patients who are 60 years of age or older. Gemtuzumab ozogamicin is an alternative to chemotherapy for these patients.
This medicine is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form:
- Injection (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Mylotarg
† Not commercially available in Canada.